Stay updated on Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial page.

Latest updates to the Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check37 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed study objectives and descriptions related to a clinical trial for nimotuzumab and nivolumab in treating advanced non-small cell lung cancer. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference51%
- Check44 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check52 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check88 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial page.